Solengepras is a potentially first-in-class, oral, non-dopaminergic investigational therapy in development for Parkinson's ...

People with chronic cocaine use can experience cognitive impairments and motor dysfunction that can be mitigated with antioxidant or anti-inflammatory agents; this supports the authors’ claim that ...

New evidence suggests that prenatal exposure to tetrahydrocannabinol (THC) could increase the risk of opioid addiction later ...

Researchers found that caffeine blocks alcohol’s ability to increase dopamine in brain reward areas, potentially reducing ...